Medindia10h
U.S. Renal Care Enrolled First Patients in the VOICE Collaborative Clinical Trial of Vafseo® (vadadustat) for CKD Patients on Dialysis
Outcomes study will assess mortality and hospitalization in patients treated with Vafseo compared to current standard of care "We look forward to begin treating CKD anemia patients on dialysis with ...
The Hospitalist1d
When Should I Transfuse My Adult Hospitalized Patient Who Has Anemia?
The 2023 AABB guidelines overall favor a restrictive transfusion strategy, recommending RBC transfusion for hemoglobin <7 ...
Daily1d
Roxadustat effective in patients with CKD with varying blood CRP levels, reveals research
A new study published in the journal of BMC Nephrology showed that the effectiveness of roxadustat is comparable at varying ...
Medscape1d
Sotagliflozin Helps Manage Anemia in Patients With Type 2 Diabetes and Chronic Kidney Disease
Sotagliflozin, a dual SGLT1/2 inhibitor, increased hemoglobin levels in patients with type 2 diabetes and chronic kidney ...
Crohn’s disease is a lifelong condition, but proper treatment makes all the difference
Crohn’s disease may be a lifelong condition, but today, there are an abundance of effective treatments that can help bring relief to your symptoms and reduce your risk of experiencing more serious ...
Numerous factors can cause kidney disease. Here are the most common ones.
AKI - the other main type of kidney disease - can be caused by dehydration, blood loss, urinary tract obstructions such as ...
Too Old to Operate5d
Impact of HIF-PHIs on Hemoglobin and Erythrocyte Indices in CKD
The following is a summary of “Erythrocyte indices and response to hypoxia-inducible factor prolyl hydroxylase inhibitors in ...